Coastlands Capital LP
SEC insider (Form 3/4/5 filer). CIK 0002068530. 10% Owner at ADIAL PHARMACEUTICALS, INC. (ADIL) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in SAN FRANCISCO, CA.
Companies Coastlands Capital LP has filed insider reports for
- ADIAL PHARMACEUTICALS, INC. (ADIL): 10% Owner
- Pasithea Therapeutics Corp. (KTTA): 10% Owner
- Eloxx Pharmaceuticals, Inc. (ELOX): 10% Owner
Coastlands Capital LP
CIK: 0002068530
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jul 16, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
PurchaseIndirect1.2K shares at avg. $2.75$3K - Jul 14, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
PurchaseIndirect2K shares at avg. $2.65$5K - Jul 10, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
PurchaseIndirect1.7K shares at avg. $2.70$5K - Jul 9, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
PurchaseIndirect10.1K shares at avg. $2.79$28K - Jun 29, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
PurchaseIndirect25K shares at avg. $2.60$65K - Jun 17, 2026KTTA
Pasithea Therapeutics Corp.
PurchaseIndirect100K shares at avg. $0.53$53K - May 27, 2026ELOX
Eloxx Pharmaceuticals, Inc.
OtherIndirect1.3M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 |  ADIL ADIAL PHARMACEUTICALS, INC. | Purchase | 1,233 | $2.75 | $3,391 | Indirect |
| Jul 14, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | Purchase | 2,000 | $2.65 | $5,300 | Indirect |
| Jul 10, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | Purchase | 1,700 | $2.70 | $4,590 | Indirect |
| Jul 9, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | Purchase | 10,053 | $2.79 | $28,048 | Indirect |
| Jun 29, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | Purchase | 25,000 | $2.60 | $65,000 | Indirect |
| Jun 17, 2026 |  KTTA Pasithea Therapeutics Corp. | Purchase | 100,000 | $0.53 | $53,000 | Indirect |
| May 27, 2026 |  ELOX Eloxx Pharmaceuticals, Inc. | Other | 1,250,000 | - | $0 | Indirect |
1-7 of 7 transactions